Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Delta-like 4 is required for pulmonary vascular arborization and alveolarization in the developing lung
Sheng Xia, Heather L. Menden, Nick Townley, Sherry M. Mabry, Jeffrey Johnston, Michael F. Nyp, Daniel P. Heruth, Thomas Korfhagen, Venkatesh Sampath
Sheng Xia, Heather L. Menden, Nick Townley, Sherry M. Mabry, Jeffrey Johnston, Michael F. Nyp, Daniel P. Heruth, Thomas Korfhagen, Venkatesh Sampath
View: Text | PDF
Research Article Pulmonology Vascular biology

Delta-like 4 is required for pulmonary vascular arborization and alveolarization in the developing lung

  • Text
  • PDF
Abstract

The molecular mechanisms by which endothelial cells (ECs) regulate pulmonary vascularization and contribute to alveolar epithelial cell development during lung morphogenesis remain unknown. We tested the hypothesis that delta-like 4 (DLL4), an EC Notch ligand, is critical for alveolarization by combining lung mapping and functional studies in human tissue and DLL4-haploinsufficient mice (Dll4+/lacz). DLL4 expressed in a PECAM-restricted manner in capillaries, arteries, and the alveolar septum from the canalicular to alveolar stage in mice and humans. Dll4 haploinsufficiency resulted in exuberant, nondirectional vascular patterning at E17.5 and P6, followed by smaller capillaries and fewer intermediate blood vessels at P14. Vascular defects coincided with polarization of lung EC expression toward JAG1-NICD-HES1 signature and decreased tip cell-like (Car4) markers. Dll4+/lacZ mice had impaired terminal bronchiole development at the canalicular stage and impaired alveolarization upon lung maturity. We discovered that alveolar type I cell (Aqp5) markers progressively decreased in Dll4+/lacZ mice after birth. Moreover, in human lung EC, DLL4 deficiency programmed a hypersprouting angiogenic phenotype cell autonomously. In conclusion, DLL4 is expressed from the canalicular to alveolar stage in mice and humans, and Dll4 haploinsufficiency programs dysmorphic microvascularization, impairing alveolarization. Our study reveals an obligate role for DLL4-regulated angiogenesis in distal lung morphogenesis.

Authors

Sheng Xia, Heather L. Menden, Nick Townley, Sherry M. Mabry, Jeffrey Johnston, Michael F. Nyp, Daniel P. Heruth, Thomas Korfhagen, Venkatesh Sampath

×

Figure 6

Dll4 haploinsufficiency causes defective alveolarization.

Options: View larger image (or click on image) Download as PowerPoint

Dll4 haploinsufficiency causes defective alveolarization.
(A) DLL4 (red...
(A) DLL4 (red), PECAM (green), and DAPI (blue) staining indicates DLL4 is expressed in the leading EC localized in primary septa at P2 in mouse lung (left panel) and at 36 weeks in human lung (right panel). The arrows point to the DLL4+ leading EC. (B) X-gal (blue) and PECAM IHC (brown) staining shows that DLL4 is expressed in the leading EC localized in primary septa at P6 in mouse lung. The arrow points to the DLL4+ leading EC. (C) PECAM IHC (brown) and Harris (blue) staining in Dll4+/+ and Dll4+/lacZ P6 mouse lung showing blunt septa in Dll4+/lacZ compared with Dll4+/+. The arrows point to normal septa in Dll4+/+ in the left panel and blunt septa in Dll4+/lacZ in the right panel. (D) H&E staining on P2, P8, P14, and P28 Dll4+/+ and Dll4+/lacZ mouse lungs. Radial alveolar counts (RAC) (E) and mean linear intercepts (MLI) (F) at P8, P14, and P28 shown graphically. n = 5 mice/group, **P < 0.01, ***P < 0.005. Scale bars: 10 μm (A and B); 25 μm (C); 100 μm (E). Data are shown as mean ± SD. (F) Two-tailed Mann-Whitney U test.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts